Keyphrases
Antimalarial Drug Resistance
100%
Drug Resistance
100%
Individual-based
100%
Epidemiological Modeling
100%
Detrimental Effects
100%
Artemisinin Resistance
100%
Resistant Genotypes
100%
Cambodia
75%
Plasmodium Falciparum
75%
Artemisinin
50%
Artemisinin-based Combination Therapy
50%
Multidrug-resistant
50%
Zambia
25%
Long-run Risk
25%
Population Level
25%
Malaria Cases
25%
Falciparum Malaria
25%
Africa
25%
Agent-based Simulation
25%
Malaria
25%
High Transmission
25%
Number of Treatment
25%
Antimalarial Drugs
25%
Specific Model
25%
Malaria Incidence
25%
African children
25%
Number of Drugs
25%
Resistance Management Strategy
25%
Malaria Parasite
25%
Low Transmission
25%
Pharmacokinetics-pharmacodynamics (PK-PD)
25%
Human Population
25%
Artemisinin Derivatives
25%
Treatment Failure
25%
Antimalarial Activity
25%
Novel Therapies
25%
Spatial Structure
25%
Genotype-phenotype
25%
Mosquito Control
25%
Grid-based
25%
Drug Class
25%
Epidemiology
25%
Medicine and Dentistry
Antimalarial Drug Resistance
100%
Artemisinin
100%
Drug Resistance
57%
Combination Therapy
28%
Antimalarial Agent
28%
Pharmacodynamics
14%
Pharmacokinetics
14%
Prevalence
14%
Artemisinin Derivative
14%
Malaria Falciparum
14%
Malaria
14%
Plasmodium
14%
Cohort Effect
14%
Pharmacology, Toxicology and Pharmaceutical Science
Artemisinin
100%
Antimalarial Agent
100%
Drug Resistance
100%
Combination Therapy
28%
Pharmacodynamics
14%
Malaria Falciparum
14%
Malaria
14%
Prevalence
14%
Artemisinin Derivative
14%
Plasmodium
14%